download the programme

Pre-Congress
Tuesday, April 26, 2016

14.00 – 16.00

Pre-Meeting on Apheresis Registries

Thèses Room - Upon invitation only
16.00 – 19.00

WAA Pre-Congress Board Meeting

Thèses Room - Upon invitation only

Day one
Wednesday, April 27, 2016

08.00 – 09.00

Registration

09.00 – 09.20

Inauguration ceremony

Amphitheater Farabeuf

Lectures

  • 09.00
    Farhad Heshmati, Congress President
  • 09.05
    Paolo Perseghin, WAA President
  • 09.10
    Loic Guillevin, Scientific Committee President
  • 09.15
    SFH Award to Loic Guillevin
09.20 – 10.50

Session 1

Amphitheater Farabeuf - Plenary

Convalescence Plasma

Chairs: Loic Guillevin, Paolo Perseghin, Olivier Garraud
  • 09.20
    Passive immunotherapy (In the memory of JJ Lefrère)
    Farhad Heshmati
  • 09.45
    Questions
  • 09.50
    Convalescent Plasma
    Olivier Garraud
  • 10.15
    Questions
  • 10.20
    Hepatitis E in the Apheresis Population
    Gail Rock
  • 10.45
    Questions
10.50 – 11.20

Coffee break, Exhibits visit

11.20 – 12.50

Session 2

Amphitheater Farabeuf - Simultaneous

Immuno-absorption

Chairs: Lionel Rostaing, Zbigniew Szczepiorkowski, Christophe Ridel
  • 11.20
    Desimmunization for HLA and/or ABO incompatible organ grafts
    Lionel Rostaing
  • 11.45
    Adsorption technology for therapeutic Apheresis. What is done in Russia?
    Sergei Pokrovsky
  • 12.00
    Questions
  • 12.05
    Acute humoral rejection after ABO-incompatible kidney transplantation does not correlate with anti-ABO titers
    S. Beaudreuil, A. Boukadida, M. Cazenave, P. Grimbert, P. Gallon, R. Matesan, H. Francois, P. Lang and A. Durrbach
  • 12.20
    Immunoadsorption VS TPE; The chance of choice or the choice of chance
    Christophe Ridel
  • 12.35
    “Secretor donor” plasma exchange therapy in pure red cell aplasia after major abo-incompatible hematopoietic stem cell transplantation
    Maria Mariano, Mirco Bevini, Roberta Malavolti, Paola Bresciani, Angela Cuoghi and Franco Narni
  • 12.45
    Questions

Session 3

Amphitheater Pasquier - Simultaneous

Hematopoietic Stem Cell transplantation

Chairs: Jean Paul Vernant, Marina Cavazzana, Nacer Ahmed Redhouane
  • 11.20
    Gene therapy for sickle cell anemia
    Marina Cavazzana
  • 11.40
    Mobilization of HSC: History, evolution & impact
    Nabih Azar
  • 12.00
    A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel
    Paolo Perseghin
  • 12.20
    Questions
  • 12.25
    Peripheral hematopoietics stem cells collection (PHSC) by large volume leukapheresis in children
    Tahani Ali, Faihaa H. Abou Fakher
  • 12.35
    Peripheral cell collection after mobilization with plerixafor in children: don’t wait the sixth hour!
    Adrien Subervie, Nadège Rabiau, Valérie Hervé, Anne Laverroux, Emmanuelle Lopez, Pascale Halle, Richard Veyrat-Masson, Victoria Grèze, Chantal Rapatel, Fanny Chambon, Nathalie Boiret-Dupré, Justyna Kanold and Etienne Merlin
  • 12.45
    Questions
12.50 – 13.20

Lunch

13.20 – 14.20

Symposium 1: Cerus Europe B.V.

Amphitheater Farabeuf - Simultaneous

The need for increased safety for large volume plasma and RBC exchange therapies

Chair: Jean-Marc Payrat
  • 13.20
    Efficacy and electrocardiographic events of plasma exchange with amotosalen-UVA and quarantine plasma for the treatment of autoimmune TTP
    Mario Ojeda-Uribe (France)
  • 13.50
    Indications and complications of RBC exchanges in SCD and other red cell disorders
    John Porter (United Kingdom)

Symposium 2: Terumo BCT

Amphitheater Pasquier - Simultaneous

Advancing Apheresis in Neurology: Review of Neurological Disease Indications for Plasma Exchange and Plasma Exchange Options

  • 13.20
    Introduction: Focus on neurological indications, review guideline
    Miguel Lozano (Spain)
  • 13.40
    Review of neurological indications & recommendations for TPE treatment
    Laurent Magy (France)
  • 14.00
    Review plasma exchange options: centrifugal TPE versus membrane TPE
    Jan T. Kielstein (Germany)
14.20 – 15.50

Session 4

Amphitheater Farabeuf - Simultaneous

Therapeutic Plasma Exchange

Chairs: Bertrand Guidet, Ghodrat Siami, Romain Guillemain
  • 14.20
    History of Apheresis
    Ghodrat Siami
  • 14.45
    Questions
  • 14.50
    Therapeutic Plasma Exchange in ANCA-associated vasculitis
    Xavier Puéchal
  • 15.15
    Questions
  • 15.20
    Outcome and survival of therapeutic plasmapheresis perfomed in a pediatric center
    Lisa Weidner, Elisabeth Beiglböck and Volker Witt
  • 15.30
    Questions
  • 13.35
    Plasma exchange: experience of the medical intensive care unit of Oran Algeria
    Errouane Badreddine, Drouiz Ourida, Mansour Sara and Mehali Mustapha
  • 15.45
    Questions

Session 5

Amphitheater Pasquier - Simultaneous

Education session, basic aspects of Apheresis therapy

Chairs: Robert Weinstein, Hans Vrielink, Miguel Lozano
  • 14.20
    The use of SD Plasma in pediatric patients undergoing TPE
    Volker Witt
  • 14.40
    Venous access
    Ingrid de Beer
  • 15.00
    Citrate, Calcium and Magnesium metabolism and related toxicities
    Hans Vrielink
  • 15.20
    Evidence and decision making in Apheresis Medicine
    Robert Weinstein
  • 15.40
    Discussion
15.50 – 16.20

Coffee break, Exhibits visit

16.20 – 17.45

Session 6

Amphitheater Farabeuf - Simultaneous

Autoimmune diseases

Chairs: Luc Mouthon, Othaman Ilhan, Joseph Schwartz
  • 16.20
    Mechanisms of action of intravenous immunoglobulin
    Luc Mouthon
  • 16.45
    Questions
  • 16.50
    Therapeutic plasma exchange (TPE) for Guillain-Barré Syndrome (GBS): Outcomes and tolerability in a paediatric and adult cohort
    Dhieb Amel, Menif Hela, Rekik Hayet, Ben Amor Ikram, Dammak Mariem, Mhiri Chokri and Gargouri Jalel
  • 17.05
    To assess the incremental cost effectiveness of treating Guillain Barre Syndrome patient with IVIG as compared to TPE
    Ratti Ram Sharma, Ashish Maheshwari, Rekha Hans Manish Modi, Shanker Prinja, Navneet Sharma and Neelam Marwaha
  • 17.20
    Questions
  • 17.25
    Plasmapheresis safety according to indication, vascular access and technical process
    Vincent Delattre, Arnaud Lionet, François Provôt, Céline Lebas, Marie Frimat, Célia Lessore de Sainte Foy, François Glowacki, Marc Hazzan and Christian Noël
  • 17.40
    Questions

Session 7

Amphitheater Pasquier - Simultaneous

Red Blood Cell exchange

Chairs: Françoise Driss, Gösta Berlin, France Pirenne
  • 16.20
    Sickle cell disease and Hyperhemolysis: epidemiology, risk factors and new therapeutic approaches
    France Pirenne
  • 16.40
    Questions
  • 16.45
    History, operating procedure and role of the vascular access in chronic intravenous treatment
    Jan Stolba
  • 17.05
    Experience of transfusional processings by Erythrapheresis in Adults Sickle Cell Center of Martinique, 3 years already
    Gylna Loko
  • 17.25
    Questions
  • 17.30
    Clinical benefit and costs’ evaluation of erythrocytapheresis compared to manual exchange transfusion for children with sickle cell disease (SCD): a single center experience
    Laurence Dedeken, Phu Quoc Lê, Laurence Rozen, Hanane El Kenz, Sophie Huybrechts, Christine Devlack, Safiatou Diallo, Catherine Heijmans and Alina Ferster
  • 17.45
    Comparison of automated erythrocytapheresis versus manual Exchange transfusion to treat cerebral macrovasculopathy in Sickle cell anemia
    Bérengère Koehl, Julie Sommet, Laurent Holvoet, Hendy Abdoul, Priscilla Boizeau, Ghislaine Ithier, Florence Missud, Nathalie Couque, Suzanne Verlhac, Pauline Voultoury, Fatiha Sellam, André Baruche and Malika Benkerrou
  • 18.00
    Questions
18.00 – 19.30

Editorial Board Meeting for the Transfusion and Apheresis Science Journal

Club Room

Day two
Thursday, April 28, 2016

08.00 – 08.30

Registration

08.30 – 09.00

Cohn de Laval lecture

Amphitheater Farabeuf - Plenary
  • 08.30
    Introduction
    Paolo Perseghin, Kerri Gallo
  • 08.40
    Award of Cohn de Laval
    Paul Höcker
09.00 – 10.30

Session 8

Amphitheater Farabeuf - Plenary

Donor Apheresis

Chairs: Philippe Bierling, Azita Chegini, Suzanne Mathieu Nafissi
  • 09.00
    Hepatitis E and the safety of plasma products?
    Vincent Mallet
  • 09.20
    Iranian model for self-sufficiency in plasma derived medicine
    Azita Chegini
  • 09.40
    Questions
  • 09.45
    Optimal dose of platelets
    Rainer Moog
  • 10.05
    Whole blood versus Apheresis derived platelets: what to transfuse
    Miguel Lozano
  • 10.25
    Questions
10.30 – 11.00

Coffee break, Exhibits visit

11.00 – 12.30

Session 9

Amphitheater Farabeuf - Simultaneous

Peripheral Hematopoietic Stem Cell

Chairs: Christian Chabannon, Ardeshir Ghavamzadeh, Luc Douay
  • 11.00
    Mesenchymal Stem Cells for tissue repair
    Jean Jacques Lataillade
  • 11.20
    Use of Apheresis for the collection of stem and progenitor cells to correct myelo-ablation and promote hematopoietic chimerism: News and views
    Christian Chabannon
  • 11.40
    Immunotherapy and haploidentical transplantation
    Françoise Norol
  • 11.55
    Questions
  • 12.00
    First experience with the large volume leukapheresis on spectra optia Apheresis system's CMNC collection procedure
    Ines Bojanic, Ivana Vidovic, Sanja Mazic, Iva Lucija Burnac, Marija Lukic, Koraljka Gojceta, Vladimira Rimac and Branka Golubic Cepulic
  • 12.10
    Are there any differences with respect to collection efficiency and stem cell harvest composition using CMNC and MNC programs on the spectra optia (Terumo)
    Marjolein Van Heijningen-Van Den Boomgaard, Meriam Grootes and Georgine De Greef
  • 12.20
    Study of cost effectiveness and efficacity with the « just-in-time » plerixafor approach in Necker Hospital
    Laure Joseph, S. Manceau, M. Cavazzana, F. Lefrère
  • 12.30
    Questions
  • 12.35
    SFH AWARD to François Schooneman

Session 10

Amphitheater Pasquier - Simultaneous

TMA-HUS

Chairs: Eric Rondeau, William Clark
  • 11.00
    Treatment algorithm for TMA 2016
    William Clark
  • 11.25
    Questions
  • 11.30
    Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy
    Eric Rondeau
  • 11.55
    Questions
  • 12.00
    Eculizumab for Hemolytic Uremic Syndrome treatment
    Fadi Fakhouri
  • 12.25
    Questions
12.30 – 12.45

SFH AWARD to François Schooneman

12.50 – 13.30

Symposium 3: Octapharma

Amphitheater Farabeuf - Simultaneous

Practical use of therapeutic plasma exchange

Chair: Samir Saheb (France)
  • 12.50
    French recommendations of plasma transfusion
    Dan Benhamou (France)
  • 13.10
    Update in plasma exchange
    Samir Saheb (France)

Symposium 4: Fresenius Kabi

Amphitheater Pasquier - Simultaneous

Therapeutic Apheresis using the AMICUS Separator

  • 12.50
    An Academic Medical Center's Experience in optimizing stem cell collections on AMICUS
    Jeffrey Winters (United States)
  • 13.10
    Evaluation of a new Red Cell Depletion Procedure using AMICUS
    Pascale Poullin (France) and Frederick Sanderson (France)
13.30 – 14.00

Lunch

14.00 – 14.40

Symposium 5: Macopharma

Amphitheater Farabeuf - Simultaneous

Photopheresis: The off-line technique

Chair: Volker Witt
  • 14.00
    ECP, a challenge in personalized medicine
    Volker Witt (Austria)
  • 14.10
    ECP for liver transplant operational tolerance
    Miguel Blanquer (Spain)
  • 14.25
    ECP for lung GvHD
    Claudia Del Fante (Italy)

Symposium 6: Fresenius Medical Care

Amphitheater Pasquier - Simultaneous

Immunoadsorption - Effective Removal of IgG and IgE Antibodies

  • 14.00
    Severe Allergic Asthma and Importance of IgE
    Pascal Chanez (France)
  • 14.20
    Efficacy of Immunoadsorption and Conventional Plasma Exchange in the Removal of HLA Antibodies
    Christophe Mariat (France)
14.40 – 16.10

Session 11

Amphitheater Farabeuf - Simultaneous

Extra Corporeal Photo chemotherapy

Chairs: Volker Witt, Farhad Heshmati, Olivier Hequet
  • 14.40
    Allogeneic Hematopoietic Stem Transplantation: ECP for prevention of Graft-versus-Host Disease
    Mauricette Michalet
  • 15.00
    Questions
  • 15.05
    Updating mechanisms of action of ECP
    Farhad Heshmati
  • 15.25
    Questions
  • 15.30
    Extracorporeal photochemotherapy in graft-versus-host disease: changes on peripheral blood lymphocyte populations
    Joan Cid, Gloria Carbassé, Manel Juan, Carmen Martínez, Montse Rovira, Ana Isabel Faúndez, Laura Rubia and Miguel Lozano
  • 15.45
    Questions
  • 15.50
    Mini Extra Corporeal Photopheresis Single-Centre Experience
    D. Franić, S. Žlebnik, B. Musar, N. Kortnik, M. Draksler, A. Nunar Perko, M. Cukjati, P. Poženel and A. Milojković
  • 16.05
    Questions

Session 12

Amphitheater Pasquier - Simultaneous

Education session, practical issues in Cellular Therapy

Chairs: Joseph Schwartz, Wanda Koetz, Kerri Gallo
  • 14.40
    Qualifying HPC donors for unrelated Bone Marrow Transplantation
    Wanda Koetz
  • 15.00
    Prediction algorithms for Cellular Therapy collections and how to apply them in the working place
    Joseph Roig
  • 15.20
    Common Citations in FACT/JACIE Accreditation inspections & what is new for Apheresis facilities in the 6th edition of the standards
    Joseph Schwartz
  • 15.40
    HPC collection in tandem with Hemodialysis for patients with Multiple Myeloma
    Robert Weinstein
  • 16.00
    Discussions
16.10 – 16.40

Coffee break, Exhibits visit

16.40 – 18.10

Session 13

Amphitheater Farabeuf - Simultaneous

Cytapheresis (oral for abstracts)

Chairs: Miguel Lozano, Azita Chegini, Patrizia Accorsi
  • 16.40
    CD34 Apheresis collections in 4 hospitals
    Jeanette Drent-Vd Kooi and Hans Vrielink
  • 16.50
    Questions
  • 16.55
    Report of 39 peripheral blood stem cells collections on spectra optia Apheresis system using the continuous mononuclear cell collection protocol: performance assessment and engraftment data
    Frederick Sanderson, Pascale Poullin, Richard Smith, Corinne Nicolino-Brunet, Patrick Philip, Abdellaziz Chaib and Regis Costello
  • 17.05
    Questions
  • 17.10
    Evaluation of Peripheral Blood Stem Cell Mobilization and Collection in Elderly Patients
    Ali Ünal, Leylagül Kaynar, Çağrı Ünal, Ayşe Birekul, Musa Solmaz, Esra Turak, Serdar Şivgin, Bülent Eser and Mustafa Çetin
  • 17.20
    Questions
  • 17.25
    Autologous stem cell collection: starting blood transfusion and hemovigilance department activity
    Sara Bougar, N. Benseffaj and M. Essakalli
  • 17.35
    Questions

Session 14

Amphitheater Pasquier - Simultaneous

Session éducationnelle: Échange d’expériences et de pratiques entre professionnels de l’aphérèse

Développement Professionnel Continu
Continuing Professional Training Session in French
DPC EFS – Programme n°4214

Chairs: Jean Michel Boiron, Samir Saheb, Marc Hurtard, François Parquin
  • 16.40
    Cas clinique interactif: EP: Effet indésirable
    Arnaud Lionet
  • 17.05
    Photophérèse: limite liée à l'abord vasculaire; optimisation par le choix de la technique
    Hélène Barberis
  • 17.30
    Patients chroniques en aphérèse: l’impact de la technique
    Aurore Favier et Marine Crespel
  • 17.50
    Présentation DU Aphérèse pour les IDE
    Christophe Barisien
18.10 – 19.00

ESFH Board & General Assembly

Amphitheater Farabeuf - Simultaneous

SFH Board & General Assembly

Amphitheater Pasquier - Simultaneous

SFIH Board & General Assembly

Club Room - Simultaneous
20.00

Congress dinner

Marie Curie Room

Day three
Friday, April 29, 2016

08.00 – 09.30

Session 15

Amphitheater Farabeuf - Simultaneous

Donor Apheresis

Chairs: Rachid Djoudi, Véronique Deneys, Hans Vrielink
  • 08.00
    French experience of Granulocytes collection in 2015
    Geneviève Woimant
  • 08.20
    Higher Granulocyte Apheresis Yields Using the Spectra Optia has Optimized the Availability of Multiple Split Granulocyte Concentrates from Single Donors for Transfusion to Multiple Patients
    Fleur M. Aung, Benjamin Lichtiger and Emil J Freireich
  • 08.35
    Questions
  • 08.40
    Efficiency of autologous stem cell collection: comparison of three different cell separators
    Véronique Deneys, Annick Fabry, Maryse Van Hoojdonk, Anne Sonet, Marc André, Marc Bourgeois and Françoise Botson
  • 08.55
    Questions
  • 09.00
    Quality control of source and recovered plasma for fractionation
    Rainer Moog and Remo Rothe
  • 09.15
    Questions

Session 16

Amphitheater Pasquier - Simultaneous

Lipoprotein Apheresis

Chairs: Claudia Stefanutti, Arnaud Lionet, Samir Saheb
  • 08.00
    How to deal with PCSK9 Inhibitors and the other new drugs in field of lipoprotein Apheresis; Experience from Italy
    Claudia Stefanutti
  • 08.20
    Specific Lp(a) Apheresis - this is not LDL Apheresis!
    Sergei N. Pokrovsky
  • 08.40
    Questions
  • 08.45
    Lipoprotein Apheresis: Impact on pregnancy outcome in preeclampsia
    Cedric Rafat, Alexandre Hertig
  • 09.05
    Questions
  • 09.10
    MIGHTY MEDIC, the Multidisciplinary Group dedicated to Apheresis therapies
    Claudia Stefanutti
09.30 – 09.50

Coffee break, Exhibits visit

09.50 – 11.20

Session 17

Amphitheater Farabeuf - Simultaneous

Therapeutic Apheresis

Chairs: Paul Coppo, Gail Rock
  • 09.50
    TTP: one of the TMAs - how to sort it out
    Gail Rock
  • 10.10
    Questions
  • 10.15
    TTP from empiricism to target therapies
    Paul Coppo
  • 10.35
    Questions
  • 10.40
    Chronic erythrocytapheresis (C-EP) therapy to reduce iron overload in patients with sickle cell disease (SCD). A retrospective review of over 25 years of experience at a single center
    Haewon c. Kim, Noreen Dugan, David Friedman, Kenneth Richardson, Deborah Sesok-Pizzini, Stella t. Chou, Janet l. Kwiatkowski and Kwaku Ohene-Frempong
  • 10.50
    Factors influencing the efficiency and product quality in plateletpheresis
    Julian Strobel, Elisabeth Oswald and Jürgen Zingsem
  • 11.10
    Characterization of pediatric refractoriness to platelets by means of a novel technique
    Peter Kanzler

Session 18

Amphitheater Pasquier - Simultaneous

Special symposium: Qualification in Apheresis (QIA): A new international credential from ASCP for Apheresis practitioners

Chairs: Chrissy Anderson, Antonia Hagen-Coonradt
  • 09.50
    ASFA - ASCP Qualification In Apheresis (QIA) - Value of certification & benefits to the profession of Apheresis
    Chrissy Anderson
  • 10.15
    Qualification - eligibility requirements & how to do to apply for the exam
    Antonia Hagen-Conradt
  • 10.40
    Content outline & discussion of preparing for the exam
    Christine Fernandez
  • 11.05
    Discussion
11.20 – 12.00

Symposium 7: Hema T - Asahi Kasei Medical

Amphitheater Pasquier

Rheopheresis in microcirculatory disorders

Chair: Samir Saheb (France)
  • 11.20
    Indications of therapeutic Apheresis in microcirculatory disorders
    Alfonso Ramunni (Italy)
  • 11.40
    Feedback experience on the use of rheopheresis for peripheral vascular diseases
    Lionel Rostaing (France)
12.00 – 12.30

Lunch

12.30 – 14.00

Session 19

Amphitheater Farabeuf - Simultaneous

Registries

Chairs: Bernd Stegmayr, Giustina De Silvestro, Tarik Kanouni
  • 12.30
    WAA Apheresis Registry
    Bernd Stegmayr
  • 12.50
    Italian Apheresis Registry
    Giustina De Silvestro
  • 13.10
    French Apheresis Registry history, current status and prospects
    Tarik Kanouni
  • 13.30
    Canadian Registry
    Gail Rock
  • 13.50
    Panel discussion

Session 20

Amphitheater Pasquier - Simultaneous

Gestion d’un effet indésirable de type allergique au cours d’une Aphérèse

Continuing Professional Training Session in French
Action cognitive de DPC
ODPC INTS – Programme n° 13861500064

Chairs: Jean Jacques Cabaud, Christophe Barisien Pascale Poullin, Françoise Driss
  • 12.30
    Présentation du programme de DPC
    Jean Jacques Cabaud
  • 12.45
    Physiopathologie d'une réaction allergique
    David Osman
  • 13.00
    Présentation d'un cas concret avec échanges interactifs
    Françoise Driss
  • 13.15
    Présentation de référentiels de bonnes pratiques liées aux prélèvements d'aphérèse
    Françoise Driss et Christophe Barisien
  • 13.30
    La traçabilité des résultats de l’évaluation est assurée par le dispositif de vote interactif.
  • 13.45
    Les données de l’hémovigilance et de la pharmacovigilance
    Pascale Poullin
14.00 – 14.20

Coffee break, Exhibits visit

14.20 – 15.55

Session 21

Amphitheater Farabeuf - Simultaneous

Adverse effects of Apheresis

Chairs: Mehran Monchi, Antoine Huart, Yves Ozier
  • 14.20
    Metabolism of Citrate
    Mehran Monchi
  • 14.40
    Questions
  • 14.45
    Are there long term adverse events in platelet Apheresis donors
    Andy Buser
  • 15.05
    Questions
  • 15.10
    Plasmapheresis volume and blood donor adverse events: is there any relation?
    Jean-Yves Py, Murielle Barnoux, Séverine Durieux, Thierry Sapey and Carole Leclerc
  • 15.20
    Questions
  • 15.25
    The pros and cons of calcium prophylaxis in stem cell collection and plasma exchange warrants further investigation
    Fredrik Toss, Gösta Berlin, Bernd Stegmayr, Volker Witt: For the WAA Apheresis group
  • 15.35
    Questions
  • 15.40
    Changes of hemostasis caused by plasmapheresis with different replacement fluids in children
    Lisa Weidner, Elisabeth Beiglböck and Volker Witt
  • 15.50
    Questions

Session 22

Amphitheater Pasquier - Simultaneous

Therapeutic Apheresis (oral for abstracts)

Chairs: Ali Unal, Sergei N. Pokrovsky, Lionel Rostaing
  • 14.20
    Treatment of large plasma volumes using specific immunoadsorption to desensitize abo-incompatible kidney-transplant candidates
    Lionel Rostaing, Asma Allal, Arnaud del Bello, Federico Sallusto, Laure Esposito, Nicolas Doumerc, Bénédicte Debiol, Audrey Delas, Xavier Game and Nassim Kamar
  • 14.30
    Questions
  • 14.35
    Successful transplantation in abo- and HLA-incompatible living kidney-transplant patients: a report on 12 cases
    Lionel Rostaing, Béatrice Karam, Nicolas Congy-Jolivet, Valérie Hage, Federico Sallusto, Laure Esposito, Nicolas Doumerc, Bénédicte Debiol, Céline Guilbeau-Frugier, Xavier Game, Asma Allal and Nassim Kamar
  • 14.45
    Questions
  • 14.50
    Randomized, double-blind, placebo-controlled trial of ccr9-targeted leukapheresis treatment of ulcerative colitis patients
    Michael Eberhardson, Per Karlén, Petra Jones, Ludvig Linton, Martina Jones Kostalla, Emma Lindh, Barbro Jansson, Ann Du, Anders Odén, Hans Glise and Ola Winqvist
  • 15.00
    Questions
  • 15.05
    Tailored leukapheresis (TLA) treatment of Immune mediated inflammatory diseases
    Ann Du, Ludvig Linton, Barbro Jansson, Hans Glise and Ola Winqvist
  • 15.15
    Questions
  • 15.20
    Apheresis education experience
    Marleen Neyrinck and Hans Vrielink
  • 15.30
    Questions
  • 15.35
    Plasmapheresis in inflammatory myopathy
    Laurent Gilardin
  • 15.45
    Questions
15.55 – 16.20

Closing session

Amphitheater Farabeuf
16.20 – 17.20

WAA Post-Congress Board Meeting

Amphitheater Pasquier

POSTERS

  • P01
    NON INVASIVE PH MEASUREMENT TO MONITOR CHANGES DURING STORAGE OF PLATELET CONCENTRATES
    Rosa d’Ambrosio, Maria Grazia Di Girolamo, Giovanna Giuseppa Di Lemma, Martina Danzi, Maria Rosaria Dell’ Aversana, Saverio Misso
    Italy
  • P02
    STEM CELL COLLECTION EFFICIENCY AND THE EFFECT OF MODESTLY ELEVATED PRE-PROCEDURE WBC COUNTS IN MULTIPLE MYELOMA PATIENTS
    Vishesh Chhibber, Ruthmire Thelusca, Nancy Nikolis, Sandra Martinez, Ruthee Bayer, Lennart Logdberg
    USA
  • P03
    INCREASED PRODUCTION OF TYPE A PLASMA IN THE SIT ASL CE FROM 2013 TO 2015
    Paolo Chiriano, Shiriyani Imma, Caterina Sagliano, Giancarlo De Caprio, Maria Perillo, Rita Tomeo, Emilia Munno, Angela Stabile, Saverio Misso
    Italy
  • P04
    EFFECTS OF ROUTINE PLATELETPHERESIS ON MARKERS OF BONE METABOLISM: INFLUENCE OF DONOR VARIABLES AND APHERESIS-RELATED FACTORS
    Markus Dettke, Qan Chi And Ying Chen
    China
  • P05
    MULTICOMPONENT COLLECTION IN THE NETHERLANDS
    Ruud Van Dongen, Marian Klijn Velderman, Astrid Van Der Griendt
    Netherlands
  • P06
    REMOVING A/B ANTIBODIES BY IMMUNOSORBTION IN ABO-INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION DURING 2010-2015 YEARS
    A. Griskevicius, J. Audzijoniene, L. Griskevicius, M. Miglinas, D. Alekniene, L. Rimsevicius, M. Kasteckas
    Lithuania
  • P07
    EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATMENT OF CHRONIC GRAFT VERSUS HOST DISEASE
    Miriam Lanska, Alzbeta Zavrelova, Jakub Radocha, Milan Blaha, Pavel Zak
    Czech Republic
  • P08
    ADULT EXTRACORPOREAL PHOTOCHEMOTHERAPY: COMPARISON OF MNC VERSUS CMNC PROGRAM
    Anne Laverroux, Valérie Hervé-Sequeiros, Emmanuelle Lopez, Nadège Rouel, Rosa Perea, Etienne Merlin, Justyna Kanold
    France
  • P09
    LEUKOREDUCTION IN RED BLOOD CELLS: THE R-WBC ADAM SYSTEM EXPERIENCE
    Martina Danzi, Giovanna Giuseppa Di Lemma, Maria Grazia Di Girolamo, Rosa D’ Ambrosio, Adriana Valiante, Giuseppina Donciglio, Saverio Misso
    Italy
  • P10
    MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS: EVALUATING THE PREVENTIVE/RESCUE USE OF PLERIXAFORa
    Itxiar Molina, Luis Hernández
    Spain
  • P11
    PERIPHERAL VEIN CANNULAS IN APHERESIS: EX VIVO STUDY OF MAXIMUM FLOW RATES ON SPECTRA OPTIA
    Maria-Jesus Mustieles, Maria Acosta, Cristina Alba, Joan Cid, Miguel Lozano
    Spain
  • P12
    COLLECTION EFFICIENCY OF AUTOLOGOUS CD34+ HEMATOPOIETIC STEM CELLS IN PEDIATRIC PATIENTS WITH SOLID TUMORS AND LYMPHOMAS
    Olivera Serbic Nonkovic, Biljana Andric, Zorica Radonjic, Dragana Vujic
    Serbia
  • P13
    ERYTHROCYTAPHERESIS, A SUCCESSFUL ADJUNCT THERAPY IN A PATIENT WITH DONOR-TRANSMITTED MALARIA AFTER HEART TRANSPLANT
    Sandra Ortega, Ramon Ramoneda, Núria Sabé, J. González-Costello, Isabel González, Lluís Massuet
    Spain
  • P14
    TOXIC EPIDERMAL NECROLYSIS AND THROMBOCYTOPENIA-ASSOCIATED MULTIPLE ORGAN FAILURE. RAPID RESPONSE TO THERAPEUTIC PLASMA EXCHANGE
    Leandro Burgos Pratx, Pablo Camino, Walter Scordo, Horacio Salamone, Cristian Martínez, Felix Nuñez
    Argentina
  • P15
    PLATELET INTERACTION WITH NANO- AND MICROFIBROUS MATERIALS FOR THE TISSUE ENGINEERING
    Renata Prochazkova, Sarka Marikova, Jana Horakova, Katerina Pilarova, Tereza Pavlikova, Vera Jencova
    Czech Republic
  • P16
    USE OF APHERESIS PLATELET CONCENTRATE: « CLOSE RELATION SHIP BETWEEN PATIENT AND PRODUCT » (A REGIONAL EXPERIENCE IN ALGERIA)
    K. Allal-Taouli, F. Adda, S. Houmani, F. Dehri, N. Tabet, F. Boukli, A. Inal, N. Mesli
    Algeria
  • P17
    PLERIXAFOR USE IN PREVENTION OF MOBILIZATION FAILURE OF AUTOLOGOUS STEM CELL: A SINGLE-CENTER EXPERIENCE
    Ali Ünal, Leylagül Kaynar, Ayşe Birekul, Çağrı Ünal, Musa Solmaz, Esra Turak, Serdar Şivgi1, Bülent Eser, Mustafa Çetin
    Turkey
  • P18
    THERAPEUTIC PLASMA EXCHANGE IN THE TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS
    Srejić B. Velimir, Bogdanović D. Gradimir,Balint Bela, Lavrnić V. Dragana, Rakočević Stojanović M. Vidosava, Dujmović Bašuroski P. Irena, Milutinović R. Saša, Miljuš M. Dejan
    Serbia
  • P19
    EVALUATION OF PLATELET APHERESIS DONATION TO THE BLOOD TRANSFUSION CENTER BENI MESSOUS IN ALGERIA: RETROSPECTIVE STUDY OF 6 YEARS
    Nawel Ferroudj, Karima Chenoukh, Meriem Bensadok, Nadia Zidani, Mohamed Ramaoun, Meriem Belhani, Mohamed Nekkal
    Algeria
  • P20
    IMPROVED TARGETED IGE ADSORBER FOR APHERESIS
    Marwa Mostageer, Gerhard Stadlmayr, Clemens Gruber, Sabine Berg, Andreas Mairhofer, Christian Obinger, Friedrich Altmann, Arne von Bonin and Oskar W Smrzka
    Austria
  • P21
    THERAPEUTIC APHERESIS AND ITS INDICATIONS
    Azita Chegini, Moghadami M, Seraji B, Maghari A
    Iran